King's College London

Research portal

Randomized controlled trial of brain specific fatty acid supplementation in pregnant women increases brain volumes on MRI scans of their newborn infants

Research output: Contribution to journalArticle

E. Ogundipe, N. Tusor, Y. Wang, M. R. Johnson, A. D. Edwards, M. A. Crawford

Original languageEnglish
Pages (from-to)6-13
Number of pages8
JournalProstaglandins Leukotrienes and Essential Fatty Acids
Early online date21 Sep 2018
Accepted/In press19 Sep 2018
E-pub ahead of print21 Sep 2018
PublishedNov 2018

King's Authors


Docosahexaenoic acid (DHA) and arachidonic acid (ArA) are essential brain specific fatty acids (BSFA) for mammalian central nervous system development. Human brains have accelerated growth with significant increase in cerebral content of ArA and DHA during the last trimester of pregnancy and first postnatal months. This randomized double blind placebo controlled single centre trial assessed the impact of BSFA supplementation in pregnancy on newborn infants’ brain volumes. Eighty six infants born to study mothers had brain magnetic resonance imaging (MRI) scans soon after birth. Total and regional brain volumes were analyzed and related to maternal supplementation group. Males born to the BSFA supplemented mothers had significantly larger total brain volumes, total gray matter, corpus callosum and cortical volumes when compared to the placebo group. This is the first study to show maternal BSFA supplementation enhances newborn infants’ brain size and suggests differential sex sensitivity of fetal brains to pregnancy BSFA status.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454